Systematic review of alternative HIV preexposure prophylaxis care delivery models to improve preexposure prophylaxis services
- PMID: 37199602
- PMCID: PMC10366650
- DOI: 10.1097/QAD.0000000000003601
Systematic review of alternative HIV preexposure prophylaxis care delivery models to improve preexposure prophylaxis services
Abstract
Objectives: To identify types, evidence, and study gaps of alternative HIV preexposure prophylaxis (PrEP) care delivery models in the published literature.
Design: Systematic review and narrative synthesis.
Methods: We searched in the US Centers for Disease Control and Prevention (CDC) Prevention Research Synthesis (PRS) database through December 2022 (PROSPERO CRD42022311747). We included studies published in English that reported implementation of alternative PrEP care delivery models. Two reviewers independently reviewed the full text and extracted data by using standard forms. Risk of bias was assessed using the adapted Newcastle-Ottawa Quality Assessment Scale. Those that met our study criteria were evaluated for efficacy against CDC Evidence-Based Intervention (EBI) or Evidence-Informed Intervention (EI) criteria or Health Resources and Services Administration Emergency Strategy (ES) criteria, or for applicability by using an assessment based on the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework.
Results: This review identified 16 studies published between 2018 and 2022 that implemented alternative prescriber ( n = 8), alternative setting for care ( n = 4), alternative setting for laboratory screening ( n = 1), or a combination of the above ( n = 3) . The majority of studies were US-based ( n = 12) with low risk of bias ( n = 11). None of the identified studies met EBI, EI, or ES criteria. Promising applicability was found for pharmacists prescribers, telePrEP, and mail-in testing.
Conclusions: Delivery of PrEP services outside of the traditional care system by expanding providers of PrEP care (e.g. pharmacist prescribers), as well as the settings of PrEP care (i.e. telePrEP) and laboratory screening (i.e. mail-in testing) may increase PrEP access and care delivery.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosures of conflict: The authors have no conflicts of interest to disclose.
Identification of funding resource(s): There are no financial disclosures.
Figures
References
-
- Centers for Disease Control and Prevention. PrEP for HIV Prevention in the U.S https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/prep-for-hiv-preven...
-
- Duby Z, Bunce B, Fowler C, et al. “These Girls Have a Chance to be the Future Generation of HIV Negative”: Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa. AIDS and Behavior. 2023/01/01 2023;27(1):134–149. doi:10.1007/s10461-022-03750-1 - DOI - PMC - PubMed
-
- Erdengasileng A, Tian S, Green SS, Naar S, He Z. Using Twitter Data Analysis to Understand the Perceptions, Awareness, and Barriers to the Wide Use of Pre-Exposure Prophylaxis in the United States. Proceedings (IEEE Int Conf Bioinformatics Biomed). Dec 2022;2022:3000–3007. doi:10.1109/bibm55620.2022.9995568 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
